Près de 50 000 applications santé sont actuellement disponibles et de nouvelles apparaissent chaque jour. Certaines proposent des conseils individualisés, recueillent des données personnelles (poids, tension, fréquence cardiaque,…), ou délivrent des informations médicales. Leur développement se fait toutefois sans cadre prédéfini, ce qui soulève de nombreuses questions concernant leur fiabilité, la réutilisation des données collectées ou le respect de la confidentialité notamment. C’est pourquoi la HAS publie aujourd’hui un référentiel de 101 bonnes pratiques pour favoriser le développement d’applications et objets connectés sûrs, fiables et de qualité.
Minority of Apps Appear Likely to be Useful in Engaging Patients
[Current pharma apps are at the bottom of this pyramid. As you move up the pyramid, pharma would have a more difficult task to develop useful engaging apps for patients.]
A systematic search of the iOS and Android app stores for a broad set of medical conditions revealed 946 iOS apps and 1,173 Android apps. After removing non-health-care, non-patient-facing, non-English, and highly similar apps, 376 iOS apps and 569 Android apps remained (Exhibit 2).
Of the 376 iOS apps:
24 (6%) appeared to have limited engagement beyond traditional media66 (18%) were not relevant to the search condition33 (9%) had poor ratings or reviews, 63 (17%) were last updated prior to 201429 (8%) were otherwise not assessed to be useful.
Of the 569 Android apps:
89 (16%) had limited engagement56 (10%) were not relevant to the search condition8 (1%) had poor ratings or reviews, 200 (35%) were last updated prior to 201464 (11%) were otherwise not assessed to be useful.
In all, 161 (43%) iOS apps and 152 (27%) Android apps were assessed as possibly useful, of which 126 apps existed on both platforms.
Everyone loves benchmarks (and Raymond -Ed.) and TrackMaven has released a report that looks at B2B social media across 17 different industries including Pharmaceuticals, Medical, and Biotech. The report is to be commended as it includes a list of the 316 companies used in the comparison so the reader isn't left questioning the groupings. For instance "biotech" could include many different industries such as energy but by including the 10 companies in the list we can see it's all pharmaceutical and health and so extremely relevant. Medical is dominated by MedTech device companies. @klickhealth
The life-sciences industry is embracing digital to unlock innovation. We spoke to ten digital leaders at global pharmaceutical companies to understand how they focus their efforts.
The conviction that competitive differentiation will require effective digital initiatives has led many life-sciences companies to create a new leadership role, chief digital officer (CDO), to guide their digital initiatives.
To understand how these leaders see the digital future and how they are managing for success, we spoke to CDOs and their equivalents at ten pharma companies. These conversations suggest three imperatives for digital efforts: focus on the team applying the tools, not on the tools themselves; make bold, disruptive bets; and optimize the portfolio of initiatives to achieve company priorities, while taking finite resources into account.
The three imperatives are:
Focus on teams and capabilities, not toolsMake bold, disruptive betsOptimize the portfolio
According to McKinsey research, companies with advanced digital capabilities grow revenues twice as fast as peers and deliver 25% greater total returns to shareholders annually. According to the authors of a new e-book, "today's commercial mix should reflect the fact that people are now viewing digital channels close to 50% of the time, and, even more importantly, that those people seek real engagement in regards to their care.
This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age. The book notes that while the world has experienced an "explosion of health-oriented digital activity," there has been a simultaneous decline in pharma growth. The authors hope that most leaders of pharmaceutical companies can find new insights and approaches in their book.
Topics (partial list):
Pharma's Digital QuotientOut-of-Sync Pharma Marketing?Be More EngagingThink in 3DTest and Learn
The full version of this article is available to subscribers. Subscription is free. Subscribe here.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.